Have a personal or library account? Click to login
Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study Cover

Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study

Radiology and Oncology
Volume 56 (2022): Issue 3 (September 2022)
By: Nina Turnsek,  Rok Devjak,  Natalija Edelbaher,  Ilonka Osrajnik,  Mojca Unk,  Dusanka Vidovic,  Tina Jeric and  Urska Janzic  
Open Access
|Aug 2022

Authors

Nina Turnsek

nturnsek@onko-i.si

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Rok Devjak

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Natalija Edelbaher

Department of Pulmonary Diseases, University Medical Centre Maribor, Pohorje, Slovenia

Ilonka Osrajnik

Department of Pulmonary Diseases, University Medical Centre Maribor, Pohorje, Slovenia

Mojca Unk

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Dusanka Vidovic

Department of Pulmonary Diseases, University Medical Centre Maribor, Pohorje, Slovenia

Tina Jeric

AstraZeneca UK Limited, Branch office in Slovenia, Ljubljana, Slovenia

Urska Janzic

Department of Medical Oncology, University Clinic Golnik, Golnik, Slovenia
DOI: https://doi.org/10.2478/raon-2022-0025 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 371 - 379
Submitted on: Jan 31, 2022
|
Accepted on: Apr 7, 2022
|
Published on: Aug 14, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
real-world study,
non-small cell lung cancer,
epidermal growth factor receptor,
T790M testing,
attrition
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Nina Turnsek, Rok Devjak, Natalija Edelbaher, Ilonka Osrajnik, Mojca Unk, Dusanka Vidovic, Tina Jeric, Urska Janzic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 3 (September 2022)Next article